Wegovy’s list price is over $1,300 per month, but most people can pay significantly less. Depending on your insurance, income, and willingness to commit to a longer subscription, you could pay as little as $25 a month or even get it free. Here’s every realistic option for bringing the cost down.
The $25 Savings Card for Commercial Insurance
If you have private insurance through an employer or the marketplace, Novo Nordisk offers a savings card that drops your cost to $25 per month for a 28-day supply of Wegovy injections or a 30-day supply of the oral version. This is the single biggest discount most people can access, and it’s straightforward to use.
To qualify, you need a valid prescription, active commercial insurance, and you cannot be enrolled in any government healthcare program like Medicare or Medicaid. The card works at participating retail pharmacies across the U.S., though availability in Massachusetts may vary depending on state law at the time you fill the prescription. If you meet the criteria, this should be your first move.
Novo Nordisk’s Direct Subscription Plans
For people without insurance coverage for Wegovy, or who want to skip the insurance process entirely, Novo Nordisk now sells the drug through telehealth platforms like Ro, WeightWatchers, and LifeMD at reduced prices. The cost depends on how long you commit:
- Injections: $329/month for three months, $299/month for six months, or $249/month for a full year
- Oral version: $289/month for three months, $269/month for six months, or $249/month for a year
These prices include the medication itself, not just the consultation. Locking in a 12-month plan saves roughly $80 per month compared to the three-month option. That’s still a significant expense, but it’s a fraction of the retail price, and you get the brand-name drug with a prescription and clinical oversight bundled in.
Getting Wegovy Free Through Patient Assistance
Novo Nordisk runs a Patient Assistance Program for people who genuinely cannot afford the medication. You must be a U.S. citizen or legal resident and meet financial criteria that the program verifies electronically. The application doesn’t publicly list a specific income cutoff as a percentage of the federal poverty level, but the program is designed for uninsured or underinsured patients with low income. If you’re in that situation, it’s worth applying directly through NovoCare, since the worst outcome is a denial.
Making Insurance Actually Cover It
Insurance coverage for Wegovy exists but comes with hurdles. Nearly every commercial plan that covers it requires prior authorization, and the criteria are specific. Most plans follow the FDA-labeled indication: a BMI above 30, or a BMI above 27 with at least one weight-related condition like high blood pressure, type 2 diabetes, or high cholesterol. A few plans set the bar even higher, only covering patients with a BMI above 30 regardless of other conditions.
Beyond BMI, eight out of eleven commercial plans studied by researchers at Tufts Medical Center required patients to be following a reduced-calorie diet and exercise program alongside the medication. Seven required enrollment in a behavioral modification program, with most requiring that enrollment before starting the drug. These aren’t optional suggestions. If your insurer requires a documented weight management program and you haven’t done one, your claim will likely be denied.
Plans also impose continuation criteria. Every plan studied required documented weight loss of at least 4% to 5% from baseline to keep the prescription covered. Some required your BMI to drop below 25 before they’d cut off coverage. If you’re not losing weight, your insurer can stop paying.
The practical takeaway: before your doctor submits a prior authorization, make sure your medical records clearly document your BMI, any weight-related conditions, and any diet or behavioral programs you’ve participated in. The more boxes you check upfront, the less likely you are to face a denial and appeals process.
The Cardiovascular Indication Advantage
In 2024, the FDA approved Wegovy for a second use: reducing the risk of heart attack, stroke, and cardiovascular death in adults with established heart disease who also have obesity or are overweight. This matters for cost because insurers that refuse to cover Wegovy for weight loss may cover it when prescribed to prevent heart events. If you have a history of cardiovascular disease, ask your doctor whether prescribing Wegovy under this indication could change your coverage situation.
Medicare Coverage Is Coming, but Slowly
Medicare Part D currently covers Wegovy only when prescribed to reduce cardiovascular risk in adults with established heart disease and excess weight. If your doctor prescribes it for that purpose, your Part D plan must process it through its standard formulary and utilization management process, which typically means prior authorization.
For weight loss specifically, Medicare has announced a short-term demonstration program called the GLP-1 Bridge, which will cover Wegovy (both injections and tablets) for eligible beneficiaries between July 1, 2026, and December 31, 2027. If you’re on Medicare and want Wegovy for weight loss before that window opens, you’re currently paying out of pocket. The subscription plans described above would be your most affordable route.
Employer Coverage Is Expanding
If your employer doesn’t currently cover GLP-1 drugs for weight loss, that may change soon. In 2025, 19% of firms with 200 or more workers cover these medications in their largest health plan. Among companies with 5,000 or more employees, coverage jumped from 28% in 2024 to 43% in 2025. If your company’s open enrollment is approaching, it’s worth asking your HR department whether GLP-1 coverage is being added. Some employees have successfully advocated for coverage by raising it during benefits feedback periods.
Costco’s Cash Price
If you’re paying cash without any discount program, pharmacy choice matters. Costco’s Member Prescription Program lists Wegovy at $149 for a 28-day supply, which is dramatically lower than most retail pharmacies. You don’t need a Costco membership to use their pharmacy in most states, though you do need one for the member prescription program pricing. Costco’s mail order option is priced similarly at about $152. These prices can change without notice, so call ahead or check online before making the trip.
Why Compounded Semaglutide Is Risky
You’ll find compounding pharmacies and online sellers offering “semaglutide” at a fraction of brand-name prices. This is the riskiest way to cut costs. The FDA has specifically warned that some compounded semaglutide products use salt forms of the drug, such as semaglutide sodium or semaglutide acetate, which are chemically different from the active ingredient in Wegovy. The FDA says it has no information on whether these salt forms behave the same way in the body, and it is not aware of any lawful basis for using them in compounding.
Beyond the ingredient question, compounded drugs don’t go through the same manufacturing quality controls as FDA-approved medications. You’re saving money, but you’re also accepting unknown risks around potency, sterility, and effectiveness. With Novo Nordisk’s own subscription plans now available in the $249 to $329 range, the gap between legitimate and compounded options has narrowed enough that the tradeoff is harder to justify.